| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/04/2011 | CN102046632A Azo and diaza derivatives and uses thereof in phototherapy |
| 05/04/2011 | CN102046630A Pyrrolidine fused indolobenzadiazepine HCV NS5B inhibitors |
| 05/04/2011 | CN102046628A Alpha helix mimetics and methods relating thereto |
| 05/04/2011 | CN102046627A GABAA receptor modulators |
| 05/04/2011 | CN102046626A Carba-nucleoside analogs for antiviral treatment |
| 05/04/2011 | CN102046625A Bridged heterocyclic compounds and methods of use |
| 05/04/2011 | CN102046624A Tetrahydronaphthyridines and aza derivatives thereof as histamine H3 receptor antagonists |
| 05/04/2011 | CN102046621A Antiviral salts |
| 05/04/2011 | CN102046620A Novel benzothiophene oxide derivative and salt thereof |
| 05/04/2011 | CN102046618A Hydroxyquinoxalinecarboxamide derivative |
| 05/04/2011 | CN102046617A Intermediates and a process employing the intermediates for the preparation of (3-trifluoromethylsulfonyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2ylamino)-phenyl]-benzamide |
| 05/04/2011 | CN102046610A Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof |
| 05/04/2011 | CN102046609A Pyrimidine derivative having cell-protecting activity and use thereof |
| 05/04/2011 | CN102046608A 3,4-dihydropyrimidine TRPA1 antagonists |
| 05/04/2011 | CN102046605A Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors |
| 05/04/2011 | CN102046603A [4-(1-amino-ethyl)-cyclohexyl]-methyl-amine and [6-(1-amino-ethyl) -tetrahydro-pyran-3-yl]-methyl-amine derivatives as antibacterials |
| 05/04/2011 | CN102046601A Benzene or thiophene derivative and use thereof as VAP-1 inhibitor |
| 05/04/2011 | CN102046597A (hetero-)aryl cyclohexane derivatives |
| 05/04/2011 | CN102046596A Substituted cyclohexyldiamines |
| 05/04/2011 | CN102046595A Substituted 4-aminocyclohexane derivatives |
| 05/04/2011 | CN102046591A Hydroxymethylcyclohexyl amines |
| 05/04/2011 | CN102046575A Therapeutic agent for alzheimer's disease |
| 05/04/2011 | CN102046240A Novel P2X7R antagonists and their use |
| 05/04/2011 | CN102046208A Composition for external application comprising transcription factor decoy as active ingredient |
| 05/04/2011 | CN102046204A Pharmaceutical compositions comprising a complex of aminocyclohexane derivatives and cyclodextrin |
| 05/04/2011 | CN102046202A Stabilizing lipid compositions for oral pharmaceutical agents |
| 05/04/2011 | CN102046201A Inhibitor of analgesic tolerance |
| 05/04/2011 | CN102046200A Therapeutic for hepatic cancer |
| 05/04/2011 | CN102046187A Method and compositions for treatment of cancer |
| 05/04/2011 | CN102046186A Antimicrobial and antistatic polymers and methods of using such polymers on various substrates |
| 05/04/2011 | CN102046185A Composition comprising 1, 3 /1, 6 beta glucan for reducing weight |
| 05/04/2011 | CN102046184A Cream-like O/W type emulsified composition and method for producing same |
| 05/04/2011 | CN102046183A Compositions for the treatment of hair loss |
| 05/04/2011 | CN102046182A Sulfated unsaturated disaccharidic chondroitin sulfate in connective tissue protection and repair |
| 05/04/2011 | CN102046181A Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation |
| 05/04/2011 | CN102046180A Compositions and methods for immunotherapy |
| 05/04/2011 | CN102046179A Inhibitors of fatty acid amide hydrolase |
| 05/04/2011 | CN102046178A Compositions and methods for skin care |
| 05/04/2011 | CN102046177A Oral and injectable formulations of tetracycline compounds |
| 05/04/2011 | CN102046176A 5-HT3 receptor modulators, methods of making, and use thereof |
| 05/04/2011 | CN102046175A Substituted heterocycle fused gamma-carbolines solid |
| 05/04/2011 | CN102046174A Compositions and methods for extended therapy with aminopyridines |
| 05/04/2011 | CN102046173A Aqueous liquid containing gatifloxacin, method for production thereof, and method for prevention of production of precipitates during storage of the aqueous liquid at low temperature or upon freezing/thawing of the aqueous liquid |
| 05/04/2011 | CN102046172A Pharmaceutical compositions containing a crystalline form of posaconazole |
| 05/04/2011 | CN102046171A Transdermal preparation |
| 05/04/2011 | CN102046170A Methods of treating mammals with eustachian tube dysfunctions |
| 05/04/2011 | CN102046169A Methods for increasing absorption of peptides, peptidomimetics, and other gastrointestinal transport protein substrates |
| 05/04/2011 | CN102046168A PAI-1 expression and activity inhibitors for the treatment of ocular disorders |
| 05/04/2011 | CN102046167A Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof |
| 05/04/2011 | CN102046166A Methods of treating dry eye |
| 05/04/2011 | CN102046165A Methods of treating fibrotic disorders |
| 05/04/2011 | CN102046164A Combination of a nicotinic receptor partial agonist and of an acetylcholinesterase inhibitor, pharmaceutical composition containing same and use thereof in the treatment of cognitive disorders |
| 05/04/2011 | CN102046163A Use of a combination of udenafil and alfuzosin or oxybutynin for the treatment of overactive bladder. |
| 05/04/2011 | CN102046162A Solid state forms of aliskiren compounds |
| 05/04/2011 | CN102046161A Novel depigmenting compositions in the form of a petroleum jelly-free and elastomer-free anhydrous composition comprising a solubilized phenolic derivative and a retinoid |
| 05/04/2011 | CN102046160A Novel anhydrous depigmenting compositions comprising a solubilized phenolic derivative |
| 05/04/2011 | CN102046159A Novel depigmenting compositions in the form of a petroleum jelly-free and elastomer-free anhydrous composition comprising a solubilized phenolic derivative |
| 05/04/2011 | CN102046158A Oral compositions containing enhanced antibacterial combinations of antioxidants and extracts of magnolia |
| 05/04/2011 | CN102046156A Pharmaceutical composition 271 |
| 05/04/2011 | CN102046154A Pulsatile release of valsartan |
| 05/04/2011 | CN102046153A Pharmaceutical compositions comprising brivaracetam |
| 05/04/2011 | CN102046152A Pharmaceutical composition with bisphosphonate |
| 05/04/2011 | CN102046141A External preparation for skin |
| 05/04/2011 | CN102046011A Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents |
| 05/04/2011 | CN102043030A Method for measuring materials associated with niacin simvastatin sustained-release tablets by high performance liquid chromatography |
| 05/04/2011 | CN102040749A Ganoderma sinense mycelium polysaccharide refined substance as well as preparation method and use thereof |
| 05/04/2011 | CN102040748A Ganoderma sinensis mycelium anti-tumor polysaccharide component GS-C as well as preparation method and application thereof |
| 05/04/2011 | CN102040644A Tanshinone derivative as well as preparation and application thereof |
| 05/04/2011 | CN102040643A Ciclesonide nitrate derivative |
| 05/04/2011 | CN102040627A Phosphorus-containing compound and its medicament application for treatment of bone metabolism abnormity |
| 05/04/2011 | CN102040621A Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| 05/04/2011 | CN102040615A Pyrrolin naphthene base-containing cephalo antibiotic |
| 05/04/2011 | CN102040603A Brominated N-o-methoxycarbonylbenzyl tetrahydroberberine and application thereof in treatment of hyperlipidemia |
| 05/04/2011 | CN102040602A 毒蕈碱性乙酰胆碱受体拮抗剂 Muscarinic acetylcholine receptor antagonist |
| 05/04/2011 | CN102040601A 1-N-(1-azabicyalo(2,2,2) octane ether compound and application thereof |
| 05/04/2011 | CN102040600A Substituted 1-azabicyclo (2, 2, 2) octane quaternary ammonium salt and use thereof |
| 05/04/2011 | CN102040599A Pharmaceutical application of bicyclo-(2,2,2) octane pentenyl ester |
| 05/04/2011 | CN102040598A Pharmacy application of 1-aza-bicyclo (2, 2, 2) octane amyl |
| 05/04/2011 | CN102040595A 1,3,4-hiadiazine derivatives as well as preparation method and application thereof |
| 05/04/2011 | CN102040592A Coumarin azole compound with antimicrobial activity, and preparation method and medicinal application thereof |
| 05/04/2011 | CN102040591A 7-phenyl quinolone compounds |
| 05/04/2011 | CN102040588A Tyrosine kinase inhibitor and medicinal application thereof in treating malignant tumor |
| 05/04/2011 | CN102040585A Selective estrogen receptor regulator |
| 05/04/2011 | CN102040578A Method for preparing high purity tricin from bamboo leaves |
| 05/04/2011 | CN102040570A Sulfo-taxane derivative and preparation method and application thereof |
| 05/04/2011 | CN102040569A Carotinoid derivatives and preparation method and application thereof |
| 05/04/2011 | CN102040558A Substituted bicyclo(3,3,1)nonane ether compound and application thereof |
| 05/04/2011 | CN102040556A Optical isomers of indene quinazoline, preparation method and medicinal application thereof |
| 05/04/2011 | CN102040552A 1, 2-di(cyclic group)substituted benzene derivative |
| 05/04/2011 | CN102040550A Inhibitors of cytosolic phospholipase A2 |
| 05/04/2011 | CN102040549A Statin compound, preparation method and medicament application thereof in blood fat regulation |
| 05/04/2011 | CN102040538A Crystalline polymorphic forms of monosodium N-[8-(2-hydroxybenzoyl)amino]caprylate |
| 05/04/2011 | CN102040537A Crystalline polymorphic forms of monosodium N-[8-(2-hydroxybenzoyl)amino]caprylate |
| 05/04/2011 | CN102040536A Crystalline polymorphic forms of monosodium N-[8-(2-hydroxybenzoyl)amino]caprylate |
| 05/04/2011 | CN102040535A Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate |
| 05/04/2011 | CN102040517A Resveratrol derivative and application thereof to medicament |
| 05/04/2011 | CN102040516A Resveratrol derivative and medical application thereof |
| 05/04/2011 | CN102038963A Method for preparing a stabilised menthol emulsion |
| 05/04/2011 | CN102038957A Efficient cell nucleus targeted medicine vector and application thereof to preparing antineoplastic medicines |
| 05/04/2011 | CN102038956A Tumor nucleus target medicinal vector and application thereof in preparing anti-tumor medicament |